Endogenous thrombin potential, prothrombin fragment 1+2 and D-dimers during pregnancy

Thrombosis and Haemostasis

Volumn 103, Issue 2, 2010, Pages 469-471

  Dargaud, Yesim ^a,b   Hierso, Stephanie ^a   Rugeri, Lucia ^a   Battie, Catherine ^a   Gaucherand, Pascal ^a   Negrier, Claude ^a,b   Trzeciak, M Christine ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b University Lyon 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; D DIMER; FIBRINOGEN; PROTHROMBIN; THROMBIN;

ADULT; BLEEDING; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; FIBRINOGEN BLOOD LEVEL; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; LETTER; MAJOR CLINICAL STUDY; OUTPATIENT; PREGNANCY; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY; THROMBOPHILIA; VENOUS THROMBOEMBOLISM;

EID: 75749126569     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH09-10-0679     Document Type: Letter

References (16)

1. Holmes VA, Walalce JMW. Haemostasis in normal pregnancy: a balancing act? Biochem Soc Trans 2005; 33: 428-432.
2. Zöller B, Holm J, Svensson P, et al. Elevated levels of prothrombin activation fragment 1 + 2 in plasma from patients with heterozygous Arg506 to Gln mutation in the factor V gene (APC-resistance) and/or inherited protein S deficiency. Thromb Haemost 1996; 75: 270-274.
3. Eichinger S, Weltermann A, Philipp K, et al. Prospective evaluation of hemostatic system activation and thrombin potential in healthy pregnant women with and without factor V Leiden. Thromb Haemost. 1999; 82: 1232-1236.
4. Kjellberg U, Andersson NE, Rosen S, et al. APC reisistance and other haemostatic variables during pregnancy and puerperium. Thromb Haemost 1999; 81: 527-531.
5. Bombeli T, Raddatz-Mueller P, Fehr J. Coagulation activation markers do not correlate with the clinical risk of thrombosis in pregnant women. Am J Obstet Gynecol 2001; 184: 382-389.
6. Curvers J, Thomassen MC, Rimmer J, et al. Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance test. Thromb Haemost. 2002; 88: 5-11.
7. Rosenkranz A, Hiden M, Leschnik B, et al. Calibrated automated thrombin generation in normal uncomplicated pregnancy. Thromb Haemost. 2008; 99: 331-337.
8. Dargaud Y, Trzeciak MC, Bordet JC, et al. Use of calibrated automated thrombinography +/- thrombomodulin to recognise the prothrombotic phenotype. J Thromb Haemost 2006; 6: 562-567.
9. Hemker HC, Giesen P, Al Dieri R, et al. Calibarated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 2003; 33: 4-15.
10. Bremme KA. Haemostatic changes in pregnancy. Best Pract Res Clin Haematol 2003; 16: 153-168.
11. Arkel YS, Paidas MJ, Ku DH. The use of coagulation activation markers (soluble fibrin polymer, prothrombin fragment 1.2, thrombin-antithrombin, and D dimer) in the assessment of hypercoagulability in patients with inherited and acquired prothrombotic disorders. Blood Coagul Fibrinolysis 2002; 13: 199-205.
12. Greenberg CS, Hursting MJ, Macik BG, et al. Evaluation of preanalytical variables associated with measurement of prothrombin fragment 1.2. Clin Chem 1994; 40: 1962-1969.
13. Astermark J, Tengborn L, Hedner U, et al. Anti- and procoagulant activities in factor VII-deficient subjects. Thromb Res 2001; 101: 435-440.
14. Kulkarni AA, Lee CA, Kadir RA. Pregnancy in women with congenital factor VII deficiency. Haemophilia 2006; 12: 413-416.
15. Kline JA, Williams GW, Hernandez-Nino J. D-Dimer Concentrations in Normal Pregnancy: New Diagnostic Thresholds Are Needed. Clin Chem 2005; 51: 825-829.
16. Blanco-Molina A, Trujillo-Santos J, Criado J, et al., for the RIETE Investigators. Venous thromboembolism during pregnancy or postpartum: findings from the RIETE Registry. Thromb Haemost 2007; 97: 186-190.